Characterization and Quantification of Microplastics and Nanoplastics (MNPs) in Human Blood
Closed Pre-Solicitation Posted
- Solicitation number
- 000HCNBC-2026-99178
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541380 Testing Laboratories and Services
- Place of performance
- Atlanta, Georgia 30341, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention intends to award a sole-source firm fixed price contract to Columbia University for laboratory analyses and collaborative research to characterize microplastics and nanoplastics in human blood, with responses due by 3:00 PM ET on June 19, 2026. This procurement is not subject to competitive set-aside. Work will be performed September 15, 2026 through September 14, 2028.
The scope encompasses validation of extraction and measurement protocols, quantification and characterization of microplastics and nanoplastics in biological matrices, and assessment of variability in detection using advanced analytical instrumentation. CDC will integrate its laboratory expertise with the contractor's specialized analytical capabilities to establish reliable measurement approaches and advance scientific understanding of detection methodologies.
The Government is procuring under the authority of FAR 12.102 and 41 U.S.C. § 1901 and 1903, which permits negotiation with a single source. This notice invites interested parties to identify capability and submit proposals, though the Government has indicated its intent to award to Columbia University without competition. All responses received prior to the June 19 deadline will be considered; the Government reserves discretion to conduct a competitive procurement based on responses received. Submit quotations or responses by email to the Contract Specialist at zwh7@cdc.gov. NAICS 541380 (Testing Laboratories and Services); PSC R425 (Support—Professional: Engineering/Technical).
Notice text
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price contract to Columbia University to perform laboratory analyses and collaborative research activities to characterize MNPs, validate extraction and measurement protocols, and assess variability in MNP detection using advanced analytical instrumentation. The work will integrate CDC laboratory expertise with specialized analytical capabilities provided by the contractor to establish reliable measurement approaches and improve the scientific understanding of MNP detection in biological matrices. The anticipated period of performance is 09/15/2026 through 09/14/2028.
This contract action is for services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 12.102 and 41 U.S.C. § 1901 and 1903 (an interested persons may identify their interest and capability to respond to the requirement or submit proposals).
This notice of intent is not a request for competitive quotations; however, all quotations/responses received prior to the date and time below will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to Contract Specialist at zwh7@cdc.gov by 3:00PM (ET) on 06/19/2026.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity